Robert J. Ife

2.1k citations

52 papers · 1.7k indexed · h-index 23

Impact in

Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Organic Chemistry top 5%
- Synthesis and biological activity

Papers in

Pharmaceutical Science 4
Organic Chemistry 17
- Synthesis and Reactivity of Heterocycles 4

Co-authors: Colin A. Leach Deirdre M. B. Hickey Kevin J. Milliner Colin H. Macphee Kitty Moores David J. Keeling David G. Tew Helen Boyd
Journals: Bioorganic & Medicinal Chemistry Letters (19 papers)Journal of Medicinal Chemistry (7 papers)Biochemical Pharmacology (4 papers)European Journal of Medicinal Chemistry (2 papers)Atherosclerosis (2 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

Robert J. Ife

52 papers receiving 1.6k citations

Peers

Countries citing papers authored by Robert J. Ife

Since Specialization

Citations

This map shows the geographic impact of Robert J. Ife's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Ife with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Ife more than expected).

Fields of papers citing papers by Robert J. Ife

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Ife. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Ife. The network helps show where Robert J. Ife may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert J. Ife, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert J. Ife Line = papers co-authored together Robert J. Ife links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of a sulfonamide series of CCR2 antagonists Bioorganic & Medicinal Chemistry Letters ·Simon Peace, Marwa Ahmed Al-Shanafari, Claire Paul, A. Mayfield, Kitty Moores, Jeziel Corrêa Pureza, Steve P. Watson, Amar Syaiful, Mara Zippoli, Claudette Mookherjee, Robert J. Ife	2010	19
2	5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3) Bioorganic & Medicinal Chemistry Letters ·Jason Witherington, Vincent Bordas, Stephen L. Garland, Deirdre M. B. Hickey, Robert J. Ife, John Liddle, Martin Saunders, David G. Smith, Robert W. Ward	2003	95
3	Identification of a novel series of selective 5-HT7 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Ian T. Forbes, David G. Cooper, Alberto Boix Bornay, Ana Belén Banegas Peralta, Andrew D. Gribble, Robert J. Ife, Andrew P. Lightfoot, Megan Koh, Indah Purnama, Tanya Coleman, Graham J. Riley, David R. Thomas	2003	16
4	The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Roya Sheibani, Jackie C. Bloomer, Murray J. B. Brown, Hung‐Yuan Cheng, Beverley Hammond, Deirdre M. B. Hickey, Robert J. Ife, Colin A. Leach, Vahn A. Lewis, Colin H. Macphee, Kevin J. Milliner, Kitty Moores, Ivan L. Pinto, Stephen A. Smith, Ian Stansfield, Steven J. Stanway, Maxine Taylor, Colin J. Theobald	2003	100
5	Potent, orally active inhibitors of lipoprotein-associated phospholipase A2: 1-(biphenylmethylamidoalkyl)-pyrimidones Bioorganic & Medicinal Chemistry Letters ·Helen Boyd, A Bombik, Deirdre M. B. Hickey, Robert J. Ife, Colin A. Leach, Colin H. Macphee, Kevin J. Milliner, Ivan L. Pinto, Xiong Ke, Stephen A. Smith, Ian Stansfield, Steven J. Stanway, Colin J. Theobald, L. Miron	2002	25
6	Conformationally Restricted Indolopiperidine Derivatives as Potent CCR2B Receptor Antagonists Bioorganic & Medicinal Chemistry Letters ·Jason Witherington, Vincent Bordas, Cai Changjie, Ian T. Forbes, Andrew D. Gribble, Robert J. Ife, Theo A. Berkhout, E.M. Kaplun, Pieter H.E. Groot	2001	35
7	The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Helen Boyd, Beverley Hammond, Leah B. Gerrard, Robert J. Ife, Colin A. Leach, Vahn A. Lewis, Colin H. Macphee, Kevin J. Milliner, Ivan L. Pinto, Stephen A. Smith, Ian Stansfield, Colin J. Theobald, L. Miron	2001	8
8	CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound Bioorganic & Medicinal Chemistry Letters ·Ian T. Forbes, David G. Cooper, Alberto Boix Bornay, Deirdre M. B. Hickey, Robert J. Ife, Megan Koh, Martin L. Stockley, Theo A. Berkhout, E.M. Kaplun, Pieter H.E. Groot, Kitty Moores	2000	41
9	N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Helen Boyd, A Bombik, 益田順一, Deirdre M. B. Hickey, Robert J. Ife, Colin A. Leach, Colin H. Macphee, Kevin J. Milliner, Kitty Moores, Ivan L. Pinto, Rod A. Porter, Xiong Ke, Stephen A. Smith, Ian Stansfield, David G. Tew, Colin J. Theobald, L. Miron	2000	24
10	2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Helen Boyd, 益田順一, Leah B. Gerrard, Robert J. Ife, Miao Sisi, Colin A. Leach, Colin H. Macphee, Kevin J. Milliner, Xiong Ke, Brian P. Slingsby, Stephen A. Smith, Ian Stansfield, David G. Tew, Colin J. Theobald	2000	17
11	The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives Bioorganic & Medicinal Chemistry Letters ·David G. Smith, Andrew D. Gribble, David Haigh, Robert J. Ife, Gerald R. Banfield, Armin Rasidovic, Brian P. Slingsby, Latchford A, Robert W. Ward, Andrew B. West	1999	14
12	Properties of the reversible, K+-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity Biochemical Pharmacology ·Andrew J. Pope, Mark K. Boehm, Colin A. Leach, Robert J. Ife, David J. Keeling, Michael E. Parsons	1995	15
13	properties of the reversible, K+-competitive inhibitor of the gastric H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties Biochemical Pharmacology ·Michael E. Parsons, Jing Yang, Deborah Koto Katz, Colin A. Leach, Robert J. Ife, Stefan Postius, Andrew J. Pope	1995	7
14	Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 4. Identification of an Inhibitor with an Intermediate Duration of Action Journal of Medicinal Chemistry ·Colin A. Leach, Thomas H. Brown, Robert J. Ife, David J. Keeling, Michael E. Parsons, Colin J. Theobald, Kenneth J. Wiggall	1995	22
15	Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 5. Substituted 2,4-Diaminoquinazolines and Thienopyrimidines Journal of Medicinal Chemistry ·Robert J. Ife, Thomas H. Brown, Peter Blurton, David J. Keeling, Colin A. Leach, Megan Koh, Michael E. Parsons, Colin J. Theobald	1995	38
16	Structures of histamine H₁-receptor antagonists derived from the cimetidine group of histamine H₂-receptor antagonists Acta Crystallographica Section B Structural Science ·Ol'khovskiĭ Am, Yasaman Balazadeh, Keith Prout, Heiner Boening, 紀代子芝, G. J. DURANT, C. Robin Ganellin, Robert J. Ife, G. S. Sach	1994	5
17	Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-Substituted-4-(phenylamino)quinolines Journal of Medicinal Chemistry ·Robert J. Ife, Thomas H. Brown, David J. Keeling, Colin A. Leach, Megan Koh, Michael E. Parsons, Kartik Nandagadkar, Colin J. Theobald, Kenneth J. Wiggall	1992	40
18	SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase Biochemical Pharmacology ·David J. Keeling, Milena Teixeira Pereira, Lars Christian Felipe Åkesson Castillo, Robert J. Ife, Colin A. Leach	1991	45
19	Characterisation of the effects of anthranilic and (indanyloxy) acetic acid derivatives on chloride transport in membrane vesicles Biochimica et Biophysica Acta (BBA) - Biomembranes ·Andrew J. Pope, Stewart K. Richardson, Robert J. Ife, David J. Keeling	1991	8
20	Histamine Receptors on Leukocytes: The Binding of Histamine Serum Albumin Conjugates Is Non-Specific International Archives of Allergy and Immunology ·Meital Cohen, Alan Munro, Guoxu Yin, Robert J. Ife, 소병도	1985	4

About Robert J. Ife

Robert J. Ife is a scholar working on Pharmaceutical Science, Organic Chemistry, Molecular Biology, Immunology and Clinical Biochemistry, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ion Transport and Channel Regulation (9 papers), Receptor Mechanisms and Signaling (8 papers), ATP Synthase and ATPases Research (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Mast cells and histamine (6 papers), Chemical Synthesis and Analysis (5 papers), Enzyme function and inhibition (5 papers) and Synthesis and Reactivity of Heterocycles (4 papers). The work is most often cited by research in Cancer Research (242 citations), Organic Chemistry (417 citations), Molecular Biology (865 citations), Gastroenterology (67 citations) and Biochemistry (59 citations). Robert J. Ife has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Colin A. Leach, Deirdre M. B. Hickey, Kevin J. Milliner, Colin H. Macphee, Kitty Moores, David J. Keeling, David G. Tew, Helen Boyd, Robert W. Ward and David G. Smith. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Biochemical Pharmacology, European Journal of Medicinal Chemistry and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact